Novo CEO pressed by Senate to chop rates of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would take into consideration new talks with insurers with regard to the listing charges of Wegovy and copyright if they pledge to keep the medicines on their formularies. https://kethek.com/